Announcements | | | Best Kept Trial Secrets: What Happens in Vegas Stays in Vegas | | Don't gamble with your cases. 48 hours in Vegas can change your practice forever! Join some of TTLA's battle-tested veterans and emerging superstars in Las Vegas for a CLE experience that'll change your luck in the courtroom. February 23-25, 2012, Bellagio Hotel, Las Vegas, 8 hrs. MCLE w/ 1 hr. Ethics | Products | | | Consumer Group Questions Review of Breast Implants | | Consumer safety advocates are questioning the Food and Drug Administration about seemingly incomplete and erroneous data used to affirm the safety of silicone breast implants last year. The FDA concluded last summer that the silicone-gel implants are basically safe as long as women understand they come with complications. More than one in five women who get implants for breast enhancement will need to have them replaced within five years, the agency's report concluded. MATTHEW PERRONE, AP, Bloomberg 01/06/2012 | Read Article: Bloomberg | Laws/Cases | | | Suit Filed Over Fatal Buttocks Surgery | | Two lawsuits have been filed over the death of a Las Vegas woman in a botched plastic surgery operation on her buttocks. Authorities say the Columbian couple that performed the surgery was operating an illegal medical practice in Las Vegas. The victim died after an "unusual reaction" to lidocaine, the Las Vegas Review Journal Reports. The defendants are currently serving four to eight years in prison for the woman's death. Francis McCabe, Las Vegas Review Journal 01/04/2012 | Read Article: Las Vegas Review Journal | J&J Said to Agree to Pay $1B in Risperdal Marketing Probe | | Johnson & Johnson will pay more than $1 billion to the U.S. and most states to resolve a civil investigation into marketing of the antipsychotic Risperdal, according to people familiar with the matter. J&J, the world’s largest health products company, reached an agreement last week with the U.S. attorney in Philadelphia, according to the people, who weren’t authorized to speak about the matter. Negotiations over a possible criminal plea are still under way, they said. The U.S. government has been investigating Risperdal sales practices since 2004, including allegations the company marketed the drug for unapproved uses, Margaret Cronin Fisk, Jef Feeley and David Voreacos , Bloomberg 01/06/2012 | Read Article: Bloomberg | Healthcare | | | Report Finds Most Errors at Hospitals Go Unreported | | Hospital employees recognize and report only one out of seven errors, accidents and other events that harm Medicare patients while they are hospitalized, federal investigators say in a new report. Yet even after hospitals investigate preventable injuries and infections that have been reported, they rarely change their practices to prevent repetition of the “adverse events,” according to the study, from Daniel R. Levinson, inspector general of the Department of Health and Human Services. Robert Pear, The New York Times 01/06/2012 | Read Article: The New York Times | | | | |